文献速递眼底病与葡萄膜炎

OCT测定的中心凹周围玻璃膜疣负荷与早期及中期年龄相关性黄斑变性遗传风险之间的关联

Association Between Perifoveal Drusen Burden Determined by OCT and Genetic Risk in Early and Intermediate Age-Related Macular Degeneration.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2019-01-01

本研究纳入239只早期或中期年龄相关性黄斑变性(AMD)眼,用Zeiss Cirrus advanced RPE分析算法在中心凹周围区域测量玻璃膜疣面积和体积,并分析其与补体及高密度脂蛋白(HDL)脂质通路常见遗传变异和ARMS2/HTRA1变异的关联。结果显示,玻璃膜疣面积≥中位数与CFH风险评分风险等位基因数更多及C3、ARMS2/HTRA1风险变异独立相关,玻璃膜疣体积结果相似;同一模型分析时仅CFH评分和ARMS2/HTRA1与玻璃膜疣测量相关,HDL通路基因与玻璃膜疣参数无显著关联。

要点

  • 在早期和中期AMD眼中,CFH和ARMS2/HTRA1变异与OCT测定的玻璃膜疣负荷增加独立相关,呈等位基因剂量依赖方式。
  • 玻璃膜疣面积≥中位数与CFH风险评分风险等位基因数更多及C3、ARMS2/HTRA1风险变异独立相关。
  • HDL通路基因与玻璃膜疣参数无显著关联。

核心结论

  • 在早期和中期AMD眼中,常与晚期AMD相关的CFH和ARMS2/HTRA1变异与OCT测定的玻璃膜疣负荷增加独立相关,呈等位基因剂量依赖方式。
  • 作者认为,非晚期AMD的定量分类等生物标志物及其他OCT衍生亚表型可为临床试验提供更早期的解剖学终点,并促进AMD新疗法的开发。

研究设计与样本

  • 研究选取具有OCT影像和遗传数据的早期或中期AMD眼(n=239眼)。
  • 使用Zeiss Cirrus advanced视网膜色素上皮分析算法在以中心凹为中心的中心凹周围区域估算玻璃膜疣面积和体积测量值。
  • 采用广义估计方程和线性混合模型计算玻璃膜疣测量值与补体及HDL脂质通路常见遗传变异和ARMS2/HTRA1变异的关联,并校正年龄、性别、吸烟、体重指数和教育程度。

主要发现

  • 玻璃膜疣面积≥中位数与CFH风险评分风险等位基因数更多及C3和ARMS2/HTRA1风险变异独立相关(与无可测量玻璃膜疣眼相比)。
  • 玻璃膜疣体积获得相似结果。
  • 所有基因在同一模型中分析时,仅CFH评分和ARMS2/HTRA1与玻璃膜疣测量相关。
  • HDL通路基因与玻璃膜疣参数无显著关联。
  • 非晚期AMD分期与OCT测定的玻璃膜疣面积和体积相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose of this study was to determine associations between macular drusen parameters derived from an automatic optical coherence tomography (OCT) algorithm, nonadvanced age-related macular degeneration (AMD) stage, and genetic variants. METHODS: Eyes classified as early or intermediate AMD with OCT imaging and genetic data were selected (n = 239 eyes). Drusen area and volume measurements were estimated using the Zeiss Cirrus advanced retinal pigment epithelium analysis algorithm in a perifoveal zone centered on the fovea. Associations between drusen measurements and common genetic variants in the complement and high-density lipoprotein (HDL) lipid pathways and the ARMS2/HTRA1 variant were calculated using generalized estimating equations and linear mixed models adjusting for age, sex, smoking, body mass index, and education. RESULTS: Drusen area ≥ the median was independently associated with a higher number of risk alleles for CFH risk score and risk variants in C3 and ARMS2/HTRA1 compared with eyes with no measurable drusen. Similar results were obtained for drusen volume. When all genes were analyzed in the same model, only CFH score and ARMS2/HTRA1 were associated with drusen measurements. HDL pathway genes were not significantly related to drusen parameters. Nonadvanced AMD stages were associated with OCT-derived drusen area and volume. CONCLUSIONS: Variants in CFH and ARMS2/HTRA1, commonly associated with advanced AMD, were independently associated with an increase in drusen burden determined by OCT in an allele dose dependent manner, in eyes with early and intermediate AMD. Biomarkers such as a quantitative classification of nonadvanced AMD and other OCT-derived subphenotypes could provide earlier anatomic endpoints for clinical trials and facilitate the development of new therapies for AMD.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Seddon JM, Dossett JP, Widjajahakim R, et al. Association Between Perifoveal Drusen Burden Determined by OCT and Genetic Risk in Early and Intermediate Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2019. PMID: 31658355. doi:10.1167/iovs.19-27475

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。